Rephonic
Artwork for The Uromigos

The Uromigos

The Uromigos
Prostate Cancer
Bladder Cancer
PARP Inhibitors
Pembrolizumab
Renal Cancer
Radiotherapy
Clinical Trials
Metastatic Bladder Cancer
Kidney Cancer
ASCO GU 2024
Combination Therapy
Adjuvant Therapy
PSMA PET Imaging
TALAPRO II
BRCA
Overall Survival
EV302 Study
Hormone Therapy
Androgen Deprivation Therapy
Salvage Radiotherapy

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

PublishesDailyEpisodes491Founded6 years ago
Language
Spanish
Number of ListenersCategories
Health & FitnessMedicine

Listen to this Podcast

Artwork for The Uromigos

Latest Episodes

Laura Bukavina, Tyler Stewart and Amanda Nizam join Brian and Tom to discuss and debate a new clinical trial exploring EVP in MIBC with omission of cystectomy of clinical CR patients

Tom and Brian take the stage in London for a live podcast. With the help of several special guests from the audience, they discuss management of peri-operative therapy in bladder cancer (notably in patients who may refuse cystectomy) and also the eme... more

周術期EV+PembroのKEYNOTE-B15試験をはじめとして、大きな話題が多かった今年のASCOGU。結果の解釈から今後の臨床への影響まで語り尽くします。

En este episodio se abordan los resultados más recientes del ensayo fase 3 LITESPARK 011 (belzutifan + lenvatinib frente a cabozantinib). Brian, Tom y Bob Motzer analizan la eficacia, seguridad y las implicaciones de los resultados para la secuenciac... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

GU Cast | Urology Podcast
GU Cast | Urology PodcastProfessor Declan Murphy & Dr Renu Eapen
Two Onc Docs
Two Onc DocsSam and Karine
The Journal.
The Journal.The Wall Street Journal & Spotify Studios
Odd Lots
Odd LotsBloomberg

Recent Guests

Evan Yu
Expert in prostate cancer treatment
Episode: Episode 480: ASCO GU 2026 - PEACE-3 and BRCAway Final OS Results
Sophie Gillison
Colleague of Brian and Tom discussing ASCO GU preview
Not specified
Episode: Episode 476: ASCO GU 2026 Preview
Karine Tawagi
Oncologist specializing in bladder cancer and a presenter at the Uromigos meeting.
Episode: Episode 474: Uromigos Shorts - IO-refractory Urothelial Cancer
David Einstein
Geomedical Oncologist and leader of the Geomedical Oncology Program
Beth Israel Deaconess Medical Center, part of Dana-Farber
Episode: Episode 473: Uromigos Shorts - EMBARK and BCR Prostate Cancer
David Aggen
Faculty at Memorial Sloan Kettering
Memorial Sloan Kettering
Episode: Episode 472: Uromigos Shorts - Variant Histology Bladder Cancer
Michael Morris
Section head of prostate cancer at Memorial Sloan Kettering Cancer Center
Episode: Episode 442: The History of ARPI Development in Prostate Cancer
Scott Tagawa
Presenter of the PSMA addition study
Cornell University
Episode: Episode 451: ESMO 2025 - PSMAddition
Elena Castro
Oncologist specializing in prostate cancer therapies
Episode: Episode 450: ESMO 2025 - CAPITELLO
Chris Suarez
Researcher at Valhebron
Valhebron
Episode: Episode 446: ESMO 2025 - OPTIC and front-line RCC triplets

Hosts

Brian Rini
Co-host with focus on GU oncology, affiliated with Vanderbilt-Ingram Cancer Center; appears across many episodes.
Tom Powles
Co-host and Director of Barts Cancer Centre; senior GU oncology expert with leadership roles.

Reviews

4.8 out of 5 stars from 164 ratings
  • Excellent resource for patients anddocs

    The Uromigos keep patients and doctors informed with the very latest studies and research in urogenital cancer. I appreciate their hopeful, upbeat and revealing interviews with cutting edge researchers.

    Apple Podcasts
    5
    Tea Green
    United States6 months ago
  • Informative podcast

    This podcast is a one-stop shop for all things GU oncology. The information is balanced, up to date and relevant for anyone in this field

    Apple Podcasts
    5
    F93111111
    United Kingdom2 years ago
  • Great for staying up on GU oncology

    Drs. Powles and Rini are some of the most eminent current leaders in GU oncology. In this podcast, they discuss recent key studies in the field and really break down the key questions clinicians and patients want to know — are they clinically significant, will they change practice, and what are the next steps? Also, there are a lot of cheesy jokes which this humble listener somehow enjoys.

    Apple Podcasts
    5
    Attentive listener 12345
    United States2 years ago
  • Topical and interesting

    Great discussion of topical issues within the urology space from a engaging, experienced and knowledgeable group of oncologists.

    Apple Podcasts
    5
    Antman1805
    Australia3 years ago
  • Fantastic podcast

    This is a fantastic podcast! Great insight with provocative discussions (while keeping it lighthearted at the same time).... Thank you guys. Keep them coming....

    Apple Podcasts
    5
    Jacky4911
    United States5 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners appreciate balanced data interpretation and the hosts' ability to break down complex studies.
Audience notes the show is a valuable resource for clinicians and patients seeking up-to-date GU oncology insights.
Guests and discussions are described as engaging, thoughtful, and often humorous, which enhances accessibility of dense clinical data.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Episode 480: ASCO GU 2026 - PEACE-3 and BRCAway Final OS Results
Q: What can you tell us about the PEACE-3 trial results?
The PEACE-3 trial showed a median overall survival benefit for Enzalutamide plus Radium over Enzalutamide alone, confirming the efficacy of this combination in treating metastatic castration-resistant prostate cancer.
Episode 485: ASCO GU 2026 - LITESPARK 011: Len/Belzu vs Cabo
Q: Why should we be giving Len Belzutifan over Len Everolimus?
The combination with Belzutifan is better tolerated and offers more durable responses than giving Lenvatinib with Everolimus.
Episode 485: ASCO GU 2026 - LITESPARK 011: Len/Belzu vs Cabo
Q: What do you think of the interim analysis for overall survival and how it's trending?
The data is immature but currently favors Belzutifan plus Lenvatinib over Cabozantinib.
Episode 470: Bladder Cancer Year in Review
Q: Can you elaborate on the tolerability and safety of the therapies discussed?
The therapies were surprisingly well tolerated, with a high percentage of patients going on to receive surgery, and the safety profile aligned closely with expectations.
Episode 470: Bladder Cancer Year in Review
Q: What about adjuvant therapy?
The results for adjuvant EV Pembro are promising, but sticking closely to the protocol is essential until more trial results are in.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Uromigos

What is The Uromigos about and what kind of topics does it cover?

A big portion of episodes centers on GU cancer across kidney, bladder, and prostate domains, with frequent deep dives into pivotal trials, novel agents, and biomarker-driven strategies. The hosts typically dissect new data from major conferences, discuss real-world implications for clinicians and patients, and explore safety, sequencing, and regulatory considerations. A recurring strength is their blend of rigorous data analysis with approachable humor, plus access to a wide set of GU oncology guests offering practical insights for trial design, treatment planning, and emerging therapeutic approaches.

Where can I find podcast stats for The Uromigos?

Rephonic provides a wide range of podcast stats for The Uromigos. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Uromigos and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Uromigos get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Uromigos, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Uromigos?

Rephonic provides comprehensive predictive audience data for The Uromigos, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Uromigos have?

To see how many followers or subscribers The Uromigos has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Uromigos?

These podcasts share a similar audience with The Uromigos:

1. GU Cast | Urology Podcast
2. Two Onc Docs
3. The Journal.
4. Unholy: Two Jews on the News
5. Odd Lots

How many episodes of The Uromigos are there?

The Uromigos launched 6 years ago and published 491 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Uromigos?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Uromigos?

Rephonic pulls ratings and reviews for The Uromigos from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Uromigos?

Rephonic provides full transcripts for episodes of The Uromigos. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Uromigos?

Recent guests on The Uromigos include:

1. Evan Yu
2. Sophie Gillison
3. Karine Tawagi
4. David Einstein
5. David Aggen
6. Michael Morris
7. Scott Tagawa
8. Elena Castro

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days